Odd thyroid function tests results: interference versus non-compliance by Krzysztof C Lewandowski
MEETING ABSTRACT Open Access
Odd thyroid function tests results: interference
versus non-compliance
Krzysztof C Lewandowski
From 4th Congress of the Polish Thyroid Association 2013
Lodz, Poland. 11-13 April 2013
Despite the advent modern immunoassays, particularly
with regards to TSH measurements, clinicians still
encounter seemingly inexplicable results of thyroid func-
tion tests, for instance raised concentrations of free hor-
mones (free T4 and/or free T3) in the setting of high, or at
least not suppressed TSH concentrations. Though cases of
TSH-oma or thyroid hormone resistance do exist, they are
in fact rare, while some “strange” thyroid function tests
results can be commonly explained either by a laboratory
error or patient’s non-compliance with L-thyroxine treat-
ment. In the latter case, a patient might deny any compli-
ance problems, while a combination of raised TSH
accompanied by an increased free T4 (±free T3) concen-
tration is typically observed. This is usually a result of
taking some extra doses of L-thyroxine prior to blood test,
in order to catch up for previously missed doses. Confir-
mation of non-compliance is essential, as it avoids the
need for lengthy and costly investigations in order to rule
out malabsorption problems, assay interference or genuine
cases of thyroid hormone resistance/TSH-oma. There are
some strategies that help to demonstrate non-compliance,
such as monitoring of thyroid function tests after con-
trolled administration of high dose of L-thyroxine. An
example of a case of a non-compliant hypothyroid patient
after thyroidectomy for Graves’ disease will be presented,
as well as a strategy that helped to elucidate this problem.
I will also present the data on the efficacy of once weekly
L-thyroxine administration in comparison to daily L-thyr-
oxine administration protocol. Such approach might be
sometimes applied in order to deal with some cases of
persistent non-compliance with L-thyroxine treatment.
Nevertheless, there are cases where abnormal results of
thyroid function tests persist, even though patient’s non-
compliance has been ruled out. In such cases, assay inter-
ference, typically caused by the presence of heterophilic
antibodies, must be suspected. These antibodies, usually
directed against rodent antigens, are actually quite com-
mon, but most modern assays contain blocking antibodies
that eliminate this problem in the majority of cases. If,
however, the titre of such antibodies is extremely high,
this may lead to abnormal test result. It should be men-
tioned that heterophilic antibody interference is not lim-
ited to results of thyroid function tests, but it may affect
all other hormonal assays that involve the use of antibo-
dies (e.g. sex steroid assays, etc) as well as other assays, for
instance measurements of cardiac troponins. The like-
lihood of presence of high titre of heterophilic antibodies
is increased in the setting of an augmented propensity for
generation of autoantibodies, particularly in cases of coex-
istent rheumatoid disorders (such as rheumatoid arthritis).
In cases of suspected assay interference, a clinician must
decide in the first instance, whether obtained results fit the
clinical picture. I shall endeavour to present a case of
suspected heterophilic antibodies interference and I will
also describe strategies to deal with such problems. The
last, but not least I will also mention recently described
cases of assay interference caused by the presence of
macro-TSH particles, that may result in abnormal TSH
measurements in a manner similar to macroprolactin.
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